In addition, it has been published that NASH patients and rodent models of NASH had greater NF-κB activation and protein expressions of NF-κB-dependent proinflammatory genes including TNF-α and MCP-1 [49, 50]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.